Dr. Juan-Nicolas Pena Sanchez Pyblications

  • Hill JE, Peña-Sánchez JN, Fernando C, Freitas AC, Fowler S. Composition and stability of the vaginal microbiota of pregnant women with inflammatory bowel disease. Inflammatory Bowel Diseases. 2021 (December), izab314, https://doi.org/10.1093/ibd/izab314.

 

  • Kuenzig ME, Bitton A, Carroll MW, Kaplan GG, Otley AR, Singh H, Nguyen GC, Griffiths AM, Stukel TA, Targownik LE, Jones JL, Murthy SK, McCurdy JD, Bernstein CN, Lix LM, Peña-Sánchez JN, Mack DR, Jacobson K, El-Matary W, Dummer T, Fung SG, Spruin S, Nugent Z, Tanyingoh D, Cui Y, Filliter C, Coward S, Siddiq S, Benchimol EI. Inflammatory bowel disease increases the risk of venous thromboembolism in children: a population-based matched cohort study. Journal of Crohn's and Colitis. 2021 (June); jjab113. https://doi.org/10.1093/ecco-jcc/jjab113

 

  • Peña-Sánchez JN, Osei JA, Marques Santos JD, Jennings D, Andkhoie M, Brass C, Bukassa Kazadi G, Johnson-Jennings M, Lu X, Porter L, Porter R, Quintin CL, Sanderson R, Teucher U, Fowler S. Increasing prevalence and stable incidence rates of inflammatory bowel disease among First Nations: Population-based evidence from a Western Canadian province. Inflammatory Bowel Diseases. 2021 (May); izab096. http://dx.doi.org/10.1093/ibd/izab096

 

  • Rohatinsky N, Boyd I, Dickson A, Fowler S, Peña-Sánchez JN, Quintin C, Risling T, Russell B, Wicks K, Wicks M. Perspectives of Healthcare Use and Access to Care for Individuals Living with Inflammatory Bowel Disease in Rural Canada. Rural and Remote Health. 2021 (April); 21(2): 6358. https://doi.org/10.22605/RRH6358

 

  • Osei JA, Peña-Sánchez JN, Fowler SA, Muhajarine N, Kaplan GG, Lix LM. Increasing prevalence and direct health care cost of Inflammatory Bowel Disease among adults: A Population-Based study from a Western Canadian Province. Journal of the Canadian Association of Gastroenterology. 2021 (March); in press, gwab003. http://dx.doi.org/10.1093/jcag/gwab003

 

  • Osei JA, Peña-Sánchez JN, Fowler SA, Muhajarine N, Kaplan GG, Lix LM. Population-based evidence from a western Canadian province of the decreasing incidence rates and trends of inflammatory bowel disease among adults. Journal of the Canadian Association of Gastroenterology. 2020 (June); in press, gwaa028. https://doi.org/10.1093/jcag/gwaa028

 

  • Marques Santos JD, Peña-Sánchez JN, Fowler SA. Patients’ Perspectives on Medication for Inflammatory Bowel Disease: A Mixed-Method Systematic Review. European Journal of Gastroenterology & Hepatology. 2020 (June) volume publish ahead of print. https://doi.org/10.1097/MEG.0000000000001861

 

  • Targownik LE, Bernstein CN, Singh H, Lix L, Tennakoon A, Leung S, Aviña-Zubieta A, Coward S, Jones J, Kaplan GG, Murthy SK, Nguyen GC, Peña-Sánchez JN. Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complication. Journal of Crohn’s and Colitis. 2020 (February); 14(10):1354-63, jjaa050. https://doi.org/10.1093/ecco-jcc/jjaa050

 

  • Targownik LE, Benchimol EI, Witt J, Bernstein CN, Singh H, Lix LM, Tennakoon A, Aviña A, Coward S, Jones J, Kuenzig E, Murthy SK, Nguyen GC, Peña-Sánchez JN, Kaplan G. The Effect of Anti-TNF Therapy on the Subsequent Direct Healthcare Costs of Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2019 (June); 25(10):1718-28. https://doi.org/10.1093/ibd/izz063

 

  • Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A, Carroll MW, Hazlewood G, Jacobson K, Jelinski S, Deardon R, Jones JL, Kuenzig ME, Leddin D, McBrien KA, Murthy SK, Nguyen GC, Otley AR, Panaccione R, Rezaie A, Rosenfeld G, Peña-Sánchez JN, Singh H, Targownik LE, Kaplan GG. Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-based Data. Gastroenterology. 2019 (April); 156(5):1345-53.e4. https://doi.org/10.1053/j.gastro.2019.01.002

 

  • Benchimol EI, Kuenzig ME, Bernstein CN, Nguyen GC, Guttmann A, Jones JL, Potter BK, Targownik LE, Catley CA, Nugent Z, Tanyingoh D, Mojaverian N, Underwood FE, Siddiq S, Otley AR, Bitton A, Carroll MW, deBruyn J, Dummer TJB, El-Matary W, Griffiths AM, Jacobson K, Leddin D, Lix LM, Mack DR, Murthy SK, Peña-Sánchez JN, Singh H, Kaplan GG. Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: A population-based study. Clinical Epidemiology. 2018 (November); 10: 1613-26. https://doi.org/10.2147/CLEP.S178056

 

  • Targownik LE, Benchimol EI, Bernstein CN, Singh H, Lix LM, Tennakoon A, Leung S, Zubieta A, Coward S, Jones JL, Kaplan G, Murthy SK, Nguyen GC, Peña-Sánchez JN. Upfront Combination Therapy, Compared with Monotherapy, for Patients Not Previously Treated with a Biologic Agent Associates with Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study. Clinical Gastroenterology and Hepatology. 2018 (August); 17(9): 1788-98.e2. https://doi.org/10.1016/j.cgh.2018.11.003

 

 

  • Peña-Sánchez JN, Lix LM, Teare GF, Li W, Fowler SA, Jones JL. Impact of an integrated model of care on outcomes of patients with inflammatory bowel diseases: Evidence from a population-based study. Journal of Crohn’s and Colitis. 2017;11(12): 1471-9. http://dx.doi.org/10.1093/ecco-jcc/jjx106 (access full text)

 

  • Benchimol EI, Kaplan GG, Otley AR, Nguyen GC, Underwood FE, Guttmann A, Jones JL, Potter BK, Catley CA, Nugent Z, Cui Y, Tanyingoh D, Mojaverian N, Bitton A, Carroll MW, deBruyn J, Dummer TJB, El-Matary W, Griffiths AM, Jacobson K, Kuenzig ME, Leddin D, Lix LM, Mack DR, Murthy S, Peña-Sánchez JN, Singh H, Targownik L, Vutcovici M, Bernstein CN. Rural and urban residence during early life is associated with risk of inflammatory bowel disease: A population-based inception and birth cohort study. American Journal of Gastroenterology. 2017; 112:1412-22. http://dx.doi.org/10.1038/ajg.2017.208

 

  • Jones J, Peña-Sánchez JN. Who Should Receive Biologic Therapy for IBD? The Rationale for the Application of a Personalized Approach. Gastroenterol Clin North Am. 2014; 43(3):425-40. http://dx.doi.org/10.1016/j.gtc.2014.05.004

IBD presentations

  • Peña-Sánchez JN, Osei JA, Rohatinsky N, Lu X, Risling T, Boyd I, Wicks K, Wicks M, Quintin CL, Dickson A, Fowler S. P629 Rural-urban inequities in inflammatory bowel disease health care access: a population-based retrospective cohort study from a Western Canadian Province. The 16th Congress of the European Crohn’s and Colitis Organization (ECCO). Online, July 3, 2021. Note: poster presentation. https://doi.org/10.1093/ecco-jcc/jjab076.749

 

  • Rohatinsky N, Russell B, Boyd I, Dickson A, Fowler S, Peña-Sánchez JN, Quintin CL, Risling T, Wicks K, Wicks M. N13 Living in rural communities with Inflammatory Bowel Disease: Perspectives on healthcare use and access to care from patients and providers in one Canadian province. The 16th Congress of the European Crohn’s and Colitis Organization (ECCO). Online, June 2021. Note: poster presentation. https://doi.org/10.1093/ecco-jcc/jjab074.827

 

  • Teucher U, Porter L, Peña-Sánchez JN, Jennings D, Brass C, Sanderson R, Porter P, Quintin CL, Johnson-Jennings M, Jessica O. miyo-máhcihowin (“good health and well-being”): Decolonizing research into Inflammatory Bowel Disease. 17th International Congress of Qualitative Inquiry (ICQI). Virtual - Urbana, United States. May 22, 2021. Note: oral presentation. ICQI program, page 167

 

  • Marques Santos JD, Fowler S, Jennings D, Brass C, Porter L, Porter R, Sanderson R, Peña-Sánchez JN. A19 Health care utilization differences between First Nations and the general population with inflammatory bowel disease in Saskatchewan. Canadian Digestive Diseases Week (CDDW). Online, March 7, 2021. Note: oral presentation, Top Clinical Research Papers Session. https://doi.org/10.1093/jcag/gwab002.018

 

  • A Shahmoradi, S Fowler, JN Peña-Sánchez. A182 Inflammatory bowel disease among seniors in Saskatchewan. Canadian Digestive Diseases Week (CDDW). Online, March 7, 2021. Note: poster presentation https://doi.org/10.1093/jcag/gwab002.180

 

  • M Patterson, M Gozdzik, JN Peña-Sánchez, S Fowler. A183 telehealth use in rural Saskatchewan and inflammatory bowel disease outcomes. Canadian Digestive Diseases Week (CDDW). Online, March 7, 2021. Note: poster presentation. https://doi.org/10.1093/jcag/gwab002.181

 

  • Osei JA, Peña-Sánchez JN, Fowler SA, Muhajarine N, Kaplan G, Lix LM. The incidence of inflammatory bowel disease is decreasing in Saskatchewan: a population-based cohort study. Canadian Digestive Diseases Week (CDDW). Montreal, February 29, 2020. Note: poster presentation. https://doi.org/10.1093/jcag/gwz047.059

 

  • Coward S, Benchimol EI, Bernstein CN, Bitton A, Carroll MW, Jelinski S, Jones JL, Kuenzig E, Leddin D, Murthy SK, Nguyen GC, Otley AR, Rezaie A, Peña-Sánchez JN, Singh H, Stach J, Targownik LE, Windsor JW, Kaplan GG. Hospitalization in inflammatory bowel disease: a population-based comparison of definitions. Canadian Digestive Diseases Week (CDDW). Montreal, February 29, 2020. Note: poster presentation. https://doi.org/10.1093/jcag/gwz047.063

 

  • Peña-Sánchez JN, Jennings D, Osei J, Andkhoie M, Brass C, Bukassa-Kazadi G, Fowler S, Johnson-Jennings M, Marques-Santos JD, Porter L, Porter R, Quintin CL, Sanderson R, Teucher U. A framework to study inflammatory bowel disease among Indigenous peoples and preliminary results from Saskatchewan, Canada. Canadian Digestive Diseases Week (CDDW). Montreal, Canada, February 28, 2020. Note: oral presentation. https://doi.org/10.1093/jcag/gwz047.003

 

  • Osei JA, Peña-Sánchez JN, Fowler SA, Muhajarine N, Kaplan G, Lix LM. P771 Increasing prevalence and direct health care cost of Inflammatory Bowel Disease: A population-based evidence from a western Canadian province. The 15th Congress of the European Crohn’s and Colitis Organization (ECCO). Vienna, February 14, 2020. Note: poster presentation. https://doi.org/10.1093/ecco-jcc/jjz203.899

 

  • Peña-Sánchez JN, Jennings D, Osei J, Andkhoie M, Brass C, Bukassa-Kazadi G, Fowler S, Johnson-Jennings M, Lu X, Marques-Santos JD, Porter L, Porter R, Quintin CL, Sanderson R, Teucher U. Prevalence and incidence rates of inflammatory bowel disease among First Nations: population-based evidence from Saskatchewan, Canada. The 15th Congress of the European Crohn’s and Colitis Organization (ECCO). Vienna, Austria, February 14, 2020. Note: poster presentation. https://doi.org/10.1093/ecco-jcc/jjz203.895

 

  • Osei JA, Peña-Sánchez JN, Fowler S, Muhajarine N, Lix L. Population-based evidence on the incidence of inflammatory bowel disease in Saskatchewan from 1999-2016. The 19th Saskatchewan Epidemiology Association Symposium. Regina, Canada, October 8, 2019. Note: poster presentation.

 

  • Marques Santos JD, Brass C, Peña-Sánchez JN, Fowler S, Jennings D. Health care utilization differences between First Nations and general population with Inflammatory Bowel Disease in Saskatchewan: A patient-oriented research proposal. The 19th Saskatchewan Epidemiology Association Symposium. Regina, Canada, October 8, 2019. Note: poster presentation, awarded as the best poster.

 

  • Peña-Sánchez JN, Andkhoie M, Brass C, Bukassa-Kazadi G, Fowler S, Jennings D, Johnson-Jennings M, Marques-Santos JD, Osei J, Porter L, Porter R, Quintin CL, Sanderson R, Teucher U. A framework and research initiative to study inflammatory bowel disease among Indigenous peoples in Saskatchewan. The 2019 Canadian Association for Health Services and Policy Research (CAHSPR) Scientific Conference. Halifax, Canada. May 30, 2019. Note: Oral presentation.

 

  • Marques Santos JD, Peña-Sánchez JN. Patients’ perspectives on medication for inflammatory bowel disease: contributions to health services planning. The 2019 Canadian Association for Health Services and Policy Research (CAHSPR) Scientific Conference. Halifax, Canada. May 30, 2019. Note: Poster presentation.

 

  • Targownik LE, Benchimol EI, Bernstein CN, Singh H, Kaplan G, Lix L, Tennakoon A, Nguyen GC, Avina-Zubieta A, Coward S, Panaccione R, Seow CH, Pena-Sanchez JN, Jones JL, Murthy SK, Kuenzig E. Su1783-Rates of Treatment Ineffectiveness After Initiating Anti-TNF Therapy: Results of a Pooled Population Based Interprovincial Analysis. The 2019 Digestive Disease Week (DDW). San Diego, USA, May 19, 2019. Note: Poster presentation. https://doi.org/10.1016/S0016-5085(19)38420-3

 

  • Wang S, Pena-Sanchez JN, Winquist B, Li W, Jones JL, Fowler SA. Sa1799-Characterization of women with inflammatory bowel disease and exposure to biologics or immunomodulators during pregnancy. The 2019 Digestive Disease Week (DDW). San Diego, USA, May 18, 2019. Note: poster presentation. https://doi.org/10.1016/S0016-5085(19)37866-7

 

  • Targownik LE, Witt JC, Tennakoon A, Bernstein CN, Singh H, Avina-Zubieta A, Kaplan G, Coward S, Peña-Sánchez JN, Nguyen GC, Kuenzig E, Murthy SK, Benchimol EI. 100-Longitudinal Changes in the Direct Costs of IBD Care in the Biologic Era. The 2019 Digestive Disease Week (DDW). San Diego, USA, May 18, 2019. Note: poster presentation. https://doi.org/10.1016/S0016-5085(19)36834-9

 

  • Targownik LT, Tennakoon A, Avina-Zubieta A, Kaplan G, Pena-Sanchez JN, Singh H, Bernstein CN. Sa1031-What is the Natural History of Persons with Adverse IBD related Outcomes While Using Anti-TNF Based Therapy. The 2019 Digestive Disease Week (DDW). San Diego, USA, May 18, 2019. Note: poster presentation. https://doi.org/10.1016/S0016-5085(19)37458-X

 

  • Hill JE, Peña-Sánchez JN, Fernando C, Freitas AC, Fowler S. The vaginal microbiome of pregnant women with inflammatory bowel disease. 4th Annual Conference Women and Their Microbes. Hamilton, Canada. March 6, 2019 Note: poster presentation.

 

  • Nero JD, Benguzzi M, Pena-Sanchez JN, Fowler S. A121-Lack of CRP response i`n Crohn’s disease associated with lower rates of biologic therapy: results of a single center case-control study. Canadian Digestive Diseases Week (CDDW). March 1, 2019. Banff, AB, Canada. Note: poster presentation. https://doi.org/10.1093/jcag/gwz006.120

 

  • Targownik LE, Witt J, Bernstein CN, Singh H, Avina-Zubieta A, Benchimol EI, Coward S, Jones J, Kaplan GG, Murthy S, Nguyen GC, Pena-Sanchez JN, Shaffer S, Tennakoon A. A1-Longitudinal changes in the direct cost of IBD care in the biologic era. Canadian Digestive Diseases Week (CDDW). March 1, 2019. Banff, AB, Canada. Note: oral presentation. https://doi.org/10.1093/jcag/gwz006.000

 

  • Osei, J, Peña-Sánchez JN. Epidemiology and direct medical cost of Inflammatory Bowel Disease in Saskatchewan: A research proposal. The 18th Saskatchewan Epidemiology Association Symposium. Saskatoon, October 3, 2018. Note: poster presentation, awarded as the second best poster.

 

  • Nero J, Benguzzi M, Pena-Sanchez JN, Ha E, Fowler S. CRP nonproducers and Crohn’s therapy: the coconut study. Resident Research Day, College of Medicine, University of Saskatchewan, June 19, 2018, Saskatoon, Canada. Note: poster presentation.

 

  • Osei J, Peña-Sanchez JN. Epidemiology and direct medical cost of Inflammatory Bowel Disease in Saskatchewan: A Population Based Study. 2018 Canadian Society for Epidemiology and Biostatistics (CSEB) Student Conference, June 15, 2018, Thunder Bay, Canada. Note: poster presentation.

 

  • Coward S, Clement F, Benchimol EI, Bernstein CN, Bitton A, Carroll MW, Hazlewood G, Jelinski S, Jones JL, Kuenzig E, Leddin D, McBrien K, Murthy SK, Nguyen GC, Otley AR, Rezaie A, Pena-Sanchez JN, Singh H, Targownik LE, and Kaplan GG. Analyzing the rising prevalence of IBD: predicting the prevalence in 2030 by age group. The 2018 Digestive Diseases Week (DDW). Washington, June 5, 2018. Note: Poster presentation of Distinction. https://doi.org/10.1016/S0016-5085(18)33324-9

 

  • Targownik LE, Tennakoon A, Bernstein C, Singh H, Lix L, Kaplan G, Pena-Sanchez JN, Murthy SK, Nguyen GC, Jones JL, Benchimol E. Continuing use of combination therapy is superior to anti-TNF monotherapy beyond 12 months: a population-based study. The 2018 Digestive Diseases Week (DDW). Washington, June 4, 2018. Note: Poster presentation of Distinction. https://doi.org/10.1016/S0016-5085(18)32822-1

 

  • Targownik LE, Tennakoon A, Bernstein CN, Singh H, Lix L, Kaplan G, Pena-Sanchez JN, Jones JL. Rates of recurrent anti-TNF treatment ineffectiveness among persons with IBD who continue to use of anti-TNF agents following an episode consistent with ineffective treatment. The 2018 Digestive Diseases Week (DDW). Washington, June 4, 2018. Note: Poster presentation. https://doi.org/10.1016/S0016-5085(18)32859-2

 

  • Targownik LE, Leung S, Singh H, Lix L, Kaplan G, Pena-Sanchez JN, Jones JL, Murthy SK, Nguyen GC, Benchimol EI, Bernstein CN. Is there still a role for immunomodulator monotherapy in IBD? The 2018 Digestive Diseases Week (DDW). Washington, June 4, 2018. Note: Poster presentation. https://doi.org/10.1016/S0016-5085(18)32873-7

 

  • Targownik LE, Dolovich C, Shafer LA, Bernstein CN, Singh H, Rosenfeld G, Leung Y, Seow CH, Metcalfe A, Pena-Sanchez JN, Jones JL, Nguyen GC, Baxter NN, Moore S, Benchimol EI. The effects of disease severity and surgical status on fertility rates in Crohn’s disease and ulcerative colitis. The 2018 Digestive Diseases Week (DDW). Washington, June 3, 2018. Note: Poster presentation. https://doi.org/10.1016/S0016-5085(18)32184-X

 

  • Targownik LE, Dolovich C, Shafer LA, Bernstein CN, Singh H, Rosenfeld G, Leung Y, Seow CH, Metcalfe A, Pena-Sanchez JN, Jones JL, Nguyen GC, Benchimol EI. Rates of prematurity and low birth weight babies among a North American cohort of women with IBD. The 2018 Digestive Diseases Week (DDW). Washington, June 3, 2018. Note: Poster presentation. https://doi.org/10.1016/S0016-5085(18)32189-9

 

  • Coward S, Clement F, Benchimol EI, Bernstein CN, Bitton A, Carroll MW, Hazlewood G, Jelinski S, Jones JL, Kuenzig E, Leddin D, McBrien K, Murthy SK, Nguyen GC, Otley AR, Rezaie A, Pena-Sanchez JN, Singh H, Targownik LE, and Kaplan GG. The rising prevalence of inflammatory bowel disease in Canada: analysing the past to predict the future. The 2018 Canadian Digestive Diseases Week (CDDW). Toronto, Canada. February 10, 2018. Note: poster presentation of distinction. https://doi.org/10.1093/jcag/gwy009.029

 

  • Miles M, Pena-Sanchez JN, Heisler C, Jones JL. The Canadian Landscape of IBD Care: Are We Keeping PACE? Preliminary Results from a Nationwide Survey. The 2018 Canadian Digestive Diseases Week (CDDW). Toronto, Canada. February 10, 2018. Note: poster presentation. https://doi.org/10.1093/jcag/gwy009.143

 

  • Wang S, Pena-Sanchez JN, Folwer SA. Pregnancy outcomes in women with inflammatory bowel disease and exposure to biologics - a prospective cohort study. The 2018 Canadian Digestive Diseases Week (CDDW). Toronto, Canada. February 10, 2018. Note: poster presentation. https://doi.org/10.1093/jcag/gwy009.104

 

  • Targownik LE, Benchimol EI, Seow C, Nguyen GC, Pena-Sanchez JN, Jones J, Metcalfe A, Dolovich C, Bernstein CN, Singh H. Canadian women with IBD are more likely to give birth to low birth weight infants. The 2018 Canadian Digestive Diseases Week (CDDW). Toronto, Canada. February 10, 2018. Note: poster presentation. https://doi.org/10.1093/jcag/gwy009.105

 

  • Peña-Sánchez JN, Lix LM, Teare GF, Li W, Fowler SA, Jones JL. A population-based study evaluating an integrated model of care for inflammatory bowel disease. The 2017 Digestive Diseases Week (DDW). Chicago, May 8, 2017. Note: poster presentation. http://dx.doi.org/10.1016/S0016-5085(17)32735-X

 

  • Targownik LE, Bernstein CN, Singh H, Nugent Z, Tennakoon A, leung S, Lix LM, Benchimol EI, Nguyen GC, Kaplan G, Pena-Sanchez JN, Jones JL, Jacobson K, Murthy SK, Bitton A. Concomitant immunomodulator is associated with a decreased risk of anti-TNF discontinuation and substitution: a population based study. The 2017 Digestive Diseases Week (DDW). Chicago, May 8, 2017. Note: poster presentation with distinction. http://dx.doi.org/10.1016/S0016-5085(17)33291-2

 

  • Targownik LE, Bernstein CN, Singh H, Tennakoon A, leung S, Nugent Z, Lix LM, Jacobson K, Pena-Sanchez JN, Kaplan G. The prevalence and predictors of anti-TNF failure in a population based sample of persons with IBD. The 2017 Digestive Diseases Week (DDW). Chicago, May 8, 2017. Note: poster presentation. http://dx.doi.org/10.1016/S0016-5085(17)31463-4

 

  • Peña-Sánchez JN, Lix LM, Teare GF, Li W, Fowler SA, Jones JL. The impact of an integrated model of care for patients with inflammatory bowel disease in Canada. The 12th Congress of the European Crohn’s and Colitis Organization (ECCO). Barcelona, February 17, 2017. Note: poster presentation. http://dx.doi.org/10.1093/ecco-jcc/jjx002.849

 

  • Peña-Sánchez JN, Yan L, Jones J, Lix L. Estimating incidence and prevalence of Crohn’s disease and ulcerative colitis: approaches to address misclassification in administrative health data. Annual meeting of the 2016 Canadian Digestive Diseases Week (CDDW). Montreal, February 28, 2016. Note: poster presentation.

 

  • Peña-Sánchez JN, Jones J, Lix L, Li W, Teare G. A population-based cohort study evaluating the impact of the Saskatchewan Multidisciplinary Inflammatory Bowel Disease Clinic. Annual meeting of the 2016 Canadian Digestive Diseases Week (CDDW). Montreal, February 28, 2016. Note: poster presentation.

 

  • Jones J, Stewart S, Peña-Sánchez JN, Fowler S, Lix L. A population-based evaluation of Inflammatory Bowel Disease drug utilization between 1975 and 2011: lessons from the past four decades. Annual meeting of the 2016 Canadian Digestive Diseases Week (CDDW). Montreal, February 28, 2016. Note: poster presentation.

 

  • Morris MW, Jones J, Zello GA, Alcorn J, Peña-Sánchez JN, Fowler SA. Calculation of faecal calprotectin in healthy and IBD pregnancy. Canadian Digestive Diseases Week (CDDW). Montreal, February 28, 2016. Note: poster presentation.

 

  • Peña-Sánchez JN, Jones J, Lix L, Li W, Teare G. Establishing the inflammatory bowel disease cohort in Saskatchewan and evaluating the impact of a multidisciplinary clinic for patients living the disease: a protocol of a collaborative research. The 15th Saskatchewan Epidemiology Association Symposium. Regina, November 5, 2015. Note: poster presentation.

 

  • Peña-Sánchez JN, Jones J, Lix L, Teare G. Evaluating an integrated model of care for patients with inflammatory bowel diseases (IBD) in Saskatchewan (SK): A population-based cohort study in progress. The 22nd Annual Life & Health Sciences Research, College of Medicine, University of Saskatchewan. Saskatoon, March 13, 2015. Note: Poster presentation.

 

  • Haskey N, Peña-Sánchez JN, Jones J, Fowler S. Development and validation of a nutrition screening tool to detect nutrition risk in Inflammatory Bowel Disease (IBD): The Saskatchewan IBD - Nutrition Risk (SaskIBD-NR). 2015 Canadian Digestive Diseases Week (CDDW), Banff, March 1, 2015. Note: Poster presentation.